Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes.

× No keyword cloud information.

12 in total

1. Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study.

Authors: Xia Sheng; Li Wei; Michael J Murphy; Thomas M MacDonald
Journal: Eur J Clin Pharmacol Date: 2009-11 Impact factor: 2.953

2. Evidence based medicine: what it is and what it isn't.

Authors: D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal: BMJ Date: 1996-01-13

3. Effects of combination lipid therapy in type 2 diabetes mellitus.

Authors: Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington
Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245

Review 4. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

Authors: Min Jun; Celine Foote; Jicheng Lv; Bruce Neal; Anushka Patel; Stephen J Nicholls; Diederick E Grobbee; Alan Cass; John Chalmers; Vlado Perkovic
Journal: Lancet Date: 2010-05-10 Impact factor: 79.321

Review 5. Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective.

Authors: Marshall Elam; Laura C Lovato; Henry Ginsberg
Journal: Curr Opin Lipidol Date: 2011-02 Impact factor: 4.776

6. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.

Authors: P McElduff; M Jaefarnezhad; P N Durrington
Journal: Heart Date: 2006-05-22 Impact factor: 5.994

Review 7. Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors: H Bryan Brewer
Journal: J Clin Endocrinol Metab Date: 2011-03-09 Impact factor: 5.958

8. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.

Authors: S Goya Wannamethee; A Gerald Shaper; Peter H Whincup; Lucy Lennon; Naveed Sattar
Journal: Arch Intern Med Date: 2011-03-14

Review 9. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis.

Authors: U Bulugahapitiya; S Siyambalapitiya; J Sithole; I Idris
Journal: Diabet Med Date: 2009-02 Impact factor: 4.359

10. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors: C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal: Lancet Date: 2010-11-08 Impact factor: 79.321